EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 376 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,149,665 | +389.7% | 112,489 | +442.1% | 0.10% | +371.4% |
| Q3 2021 | $439,000 | -19.3% | 20,749 | -30.5% | 0.02% | -16.0% |
| Q2 2021 | $544,000 | -20.6% | 29,846 | -1.6% | 0.02% | -26.5% |
| Q1 2021 | $685,000 | -1.3% | 30,331 | -12.3% | 0.03% | -10.5% |
| Q4 2020 | $694,000 | -84.1% | 34,585 | -80.7% | 0.04% | -86.0% |
| Q3 2020 | $4,373,000 | +20.9% | 178,865 | +17.4% | 0.27% | +15.3% |
| Q2 2020 | $3,616,000 | – | 152,337 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |